Cost-Effective, Scalable Manufacturing for a Life-Saving IVD Platform
Advancing Point-of-Care Diagnostics Through Design for Manufacturing (DFM) and Scalable Production
Scaling Innovation to Make Critical Neonatal Screening Accessible in Low-Resource Settings
A U.S.-based diagnostics innovator partnered with Syrma Johari MedTech Ltd. (SJML) to transform its digital microfluidics-based point-of-care (POC) prototype into a commercially scalable product. The device was designed for glucose-6-phosphate dehydrogenase (G6PD) deficiency screening—a critical test in pediatric populations. The client aimed to expand affordable diagnostic access in low- and middle-income countries, where early detection can be life-saving.
SJML provided an end-to-end solution, combining DFM, value engineering, and scalable production to ensure cost efficiency without compromising performance. The engagement resulted in reduced production lead time, significant cost savings, and accelerated CDSCO regulatory approval for Indian market entry.
Key Outcomes
- 45% faster design-to-production cycle
- 20% cost reduction through DFM, value engineering, and lean manufacturing
The Most Preferred Manufacturing Partner for In Vitro Diagnostics
Syrma Johari MedTech is a leading contract design and manufacturing company catering to global diagnostic device companies. Our manufacturing expertise spans critical IVD subsystems and consumables including microfluidic cartridges, optical detection modules, sensor-integrated PCBAs, and precision-molded disposable components.
Supported by a team of IVD domain specialists, we bring a deep understanding of diagnostic workflows such as neonatal screening, infectious and non-communicable disease detection, and chronic disease monitoring.